Literature DB >> 30802676

MiR-128 mediates negative regulation in Staphylococcus aureus induced inflammation by targeting MyD88.

Xiaofei Ma1, Shuai Guo1, Kangfeng Jiang1, Xiaoyan Wang1, Nannan Yin1, Yaping Yang1, Arshad Zahoor1, Ganzhen Deng2.   

Abstract

Acute lung injury (ALI) is a common clinical syndrome of excessive uncontrolled inflammatory response in lung tissues with high mortality rates and limited therapeutic approaches. MicroRNAs (miRNAs) are a class of small non-coding RNAs which attach at 3'UTR of mRNA for further regulation of diverse proteins. MiRNAs are a current focus in regulating the inflammatory processes. The extent of pro-inflammatory gene activated against Staphylococcus aureus (S. aureus) is still unclear. Myeloid differentiation primary response 88 (MyD88) is involved in gram positive bacteria-induced lung inflammation by Toll-like receptors (TLRs). Then MyD88 activates NF-κB through IRAKs which are in charge of inflammation. Target prediction analyses revealed MyD88, a result of projections from multiple bio-websites, to be a putative target of miR-128. Here we probe the expression of the MyD88 and miRNA in mode of inflammation. We found up-regulated expression of MyD88 and down-regulation of miR-128 after S. aureus infection in mouse lung tissues and RAW264.7 cells via qPCR and western blotting (WB) analysis. Moreover, MyD88-miR-128 interaction was validated by luciferase assays. Then, we proved that miR-128 expression caused a reduction in IκBα and p65 phosphorylation and resulted in significant reduction in secretion of inflammatory cytokines, being consistent with the deletion of MyD88 in macrophages. It revealed that miR-128 specifically blocked the further development of inflammation through MyD88 down-regulation. Finally, we demonstrated a novel role of miR-128 that it mediates negative regulation in S. aureus induced inflammation by targeting MyD88.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  ALI; MyD88; NF-κB; S. aureus; miR-128

Mesh:

Substances:

Year:  2019        PMID: 30802676     DOI: 10.1016/j.intimp.2018.11.024

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  MiR-216a alleviates LPS-induced acute lung injury via regulating JAK2/STAT3 and NF-κB signaling.

Authors:  Fanpo Kong; Yanqi Sun; Wenke Song; Yongqin Zhou; Siliang Zhu
Journal:  Hum Cell       Date:  2019-11-29       Impact factor: 4.174

2.  Sp1 S-Sulfhydration Induced by Hydrogen Sulfide Inhibits Inflammation via HDAC6/MyD88/NF-κB Signaling Pathway in Adjuvant-Induced Arthritis.

Authors:  Meng Li; Wei Hu; Ran Wang; Zhaoyi Li; Yue Yu; Yue Zhuo; Yida Zhang; Zhou Wang; Yuanye Qiu; Keyuan Chen; Qian Ding; Wei Qi; Menglin Zhu; Yizhun Zhu
Journal:  Antioxidants (Basel)       Date:  2022-04-07

3.  miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2.

Authors:  Peng Yang; Jianhua Han; Shigeng Li; Shaoning Luo; Xusheng Tu; Zhiqiang Ye
Journal:  Open Med (Wars)       Date:  2021-02-04

4.  Enhanced Expression of miR-34a Enhances Escherichia coli Lipopolysaccharide-Mediated Endometritis by Targeting LGR4 to Activate the NF-κB Pathway.

Authors:  Xiaofei Ma; Baoyi Yin; Shuai Guo; Talha Umar; Junfeng Liu; Zhimin Wu; Qingqing Zhou; Arshad Zahoor; Ganzhen Deng
Journal:  Oxid Med Cell Longev       Date:  2021-08-27       Impact factor: 6.543

5.  LncRNA LINC00461 exacerbates myocardial ischemia-reperfusion injury via microRNA-185-3p/Myd88.

Authors:  Feng Gao; Xiaochen Wang; Tingting Fan; Zhidan Luo; Mengqing Ma; Guangquan Hu; Yue Li; Yi Liang; Xianhe Lin; Banglong Xu
Journal:  Mol Med       Date:  2022-03-10       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.